Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Belinostat

EU orphan designation number: EU/3/13/1151   
Active ingredient: Belinostat
Indication: Treatment of malignant thymoma
Sponsor: Onxeo DK, Filial af Onxeo S.A., Frankrig
c/o Symbion, Fruebjergvej 3, 2100 Copenhagen Ø, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2013 Orphan Designation EMA/OD/036/13 (2013)4725 of 17/07/2013
01/10/2013 Corrigendum (2013)6436 of 27/09/2013
29/06/2015 Transfer of orphan designation EMA/OD/036/13/T/01 (2015)4502 of 25/06/2015